JP Patent

JP6866374B2 — ドラビリン、テノホビルジソプロキシルフマル酸塩およびラミブジンを含有する医薬組成物

Assigned to Merck Sharp and Dohme LLC · Expires 2021-04-28 · 5y expired

What this patent protects

Patent listed against Pifeltro.

Drugs covered by this patent

Patent Metadata

Patent number
JP6866374B2
Jurisdiction
JP
Classification
—
Expires
2021-04-28
Drug substance claim
No
Drug product claim
No
Assignee
Merck Sharp and Dohme LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.